Summary of a workshop on the role of third-party payers in clinical trials of new agents

N Engl J Med. 1983 Nov 24;309(21):1334-6. doi: 10.1056/nejm198311243092133.
No abstract available

MeSH terms

  • Blue Cross Blue Shield Insurance Plans / economics
  • Clinical Trials as Topic / economics*
  • Insurance, Health, Reimbursement / economics*
  • National Institutes of Health (U.S.)
  • Technology Assessment, Biomedical
  • United States